Sign In
Buy HIMS
$27.51
+0 (+0%)
At Close: Jun 03, 2026
Hims & Hers Health, Inc. Reports Fourth Quarter and Full Year 2025 Financial Results
04:05pm, Monday, 23'rd Feb 2026
SAN FRANCISCO--(BUSINESS WIRE)--Hims & Hers Health, Inc. (“Hims & Hers” or the “Company”, NYSE: HIMS), the leading health and wellness platform, today announced financial results for the fourt
HIMS Headwinds Ahead of Earnings
09:02am, Monday, 23'rd Feb 2026
Raul Shah braves the snow and cold to join Morning Movers from the NYSE floor. He discusses Hims & Hers (HIMS) ahead of earnings.
Hims & Hers in Free Fall: Why Analysts See Nearly 150% Upside
10:03am, Saturday, 21'st Feb 2026
With the health care sector remaining mostly flat several weeks into 2026, one of last year's success stories has turned into an investor nightmare as shares of Hims & Hers Health NYSE: HIMS continue
Super Micro Computer, Blue Owl, Hims & Hers And More: 5 Stocks Investors Couldn't Stop Buzzing About This Week
08:31am, Saturday, 21'st Feb 2026
Retail investors talked up five hot stocks this week on X and Reddit, driven by hype, earnings, AI, and news flow.
Hims & Hers Accelerates AI Preventive Care and Platform Strategy
11:56am, Friday, 20'th Feb 2026
HIMS is accelerating AI-driven preventive care with new menopause, low testosterone and multi-cancer testing, deepening its personalized digital health platform.
Hims & Hers $1.2 Billion Global Leap: Can Eucalyptus Cure its GLP-1 Ills?
11:51am, Friday, 20'th Feb 2026
Hims & Hers Health ( NYSE:HIMS ) just made a bold move to take its personalized wellness platform global.
Market Today: Amazon Overtakes Walmart; Blue Owl Rattles Credit; FDA Eyes Moderna Flu Shot
05:36pm, Thursday, 19'th Feb 2026
Guru Stock PicksLi Lu has made the following transactions:Sold out in SOCNew position in CROXStock News Stocks slip, private credit hit, oil climbs: Blue Owl Ca
Hims & Hers HUGE Acquisition News!
03:06pm, Thursday, 19'th Feb 2026
Eucalyptus will add $450 million in annual revenue growing at a triple digit rate to Hims & Hers. The risk is in using the $1 billion in cash on the balance sheet to buy more growth.
Hims & Hers to acquire Australian digital health firm Eucalyptus, expanding international footprint
01:07pm, Thursday, 19'th Feb 2026
Hims & Hers (NYSE:HIMS) announced on Thursday that it has entered a definitive agreement to acquire Australian digital health company Eucalyptus in a deal valued at up to $1.15 billion. The acquisiti
Can Platform Strength Support Hims & Hers Stock Before Q4 Earnings?
12:15pm, Thursday, 19'th Feb 2026
HIMS fourth-quarter 2025 results are likely to benefit from new specialties and global expansion, but higher costs and GLP-1 scrutiny could cloud earnings.
88 Energy has confirmed significant potential at South Prudhoe - broker
12:13pm, Thursday, 19'th Feb 2026
88 Energy Ltd (AIM:88E, ASX:88E, OTCQB:EEENF, FRA:POQ) has been flagged by Cavendish as sitting on a roughly 500mmboe opportunity at its South Prudhoe...
Hims & Hers to Acquire Eucalyptus in $1.15 Billion Deal
11:57am, Thursday, 19'th Feb 2026
Hims and Hers Health (HIMS) announced it will acquire Australia-based digital healthcare company Eucalyptus in a deal valued at up to $1.15 billion, subject to cu
Hims & Hers Health Stock Resumes Climb on Acquisition News
10:34am, Thursday, 19'th Feb 2026
At last glance, shares of Hims & Hers Health Inc (NYSE:HIMS) are up 0.5% to trade at $15.91, after the wellness company announced its $1.15 billion acquisition of Australian digital health company E
Dow Futures Down Triple Digits; Walmart Earnings in Focus
09:26am, Thursday, 19'th Feb 2026
Stock futures are lower as investors eye Walmart (WMT) earnings, U.S.-Iran tensions, and weekly jobless claims data
What Is HIMS Worth Without GLP-1? Earnings Preview
09:06am, Thursday, 19'th Feb 2026
I'm downgrading Hims & Hers Health stock to a hold amid severe regulatory and legal headwinds, which erase (or pause) the GLP-1-driven bull case. GLP-1 compounding loophole closure, FDA/DOJ scrutiny,
